Corcept Therapeutics Incorporated (CORT)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 28.80 |
| Open | 28.80 |
| Bid | 28.60 x 500 |
| Ask | 28.73 x 100 |
| Day's Range | 28.44 - 29.42 |
| 52 Week Range | 20.84 - 34.28 |
| Volume | |
| Avg. Volume | 1,034,662 |
| Market Cap | 2.98B |
| Beta (5Y Monthly) | 0.50 |
| PE Ratio (TTM) | 27.26 |
| EPS (TTM) | 1.05 |
| Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 43.60 |
Simply Wall St.3 High Insider Ownership US Growth Companies With Earnings Growth Up To 70%
As global markets experience fluctuations influenced by economic data and geopolitical tensions, investors are keenly watching the U.S. market for stable investment opportunities. High insider ownership in growth companies can be a strong signal of confidence in the company’s future, making such stocks potentially attractive in these uncertain times.
Simply Wall St.Corcept Therapeutics First Quarter 2024 Earnings: Beats Expectations
Corcept Therapeutics ( NASDAQ:CORT ) First Quarter 2024 Results Key Financial Results Revenue: US$146.8m (up 39% from...
ZacksCorcept (CORT) Q1 Earnings & Revenues Surpass Estimates
Corcept (CORT) beats on both earnings and sales in the first quarter of 2024. The company increases revenue guidance for 2024.
© 2024 Yahoo. All rights reserved.